ClassID:

20273

A61K31/285 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Compounds containing heavy metals Arsenic compounds

Recent Application in this class:
#1
20260007631
2026-01-08

TREATMENT OF CANCER USING ORGANOARSENICALS

#2
20250387364
2025-12-25

ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN

#3
20250295627
2025-09-25

PHARMACEUTICAL PRESERVATION OF CREE ACTIVATION WITH NITARSONE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

#4
20250241885
2025-07-31

ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN

#5
20250152599
2025-05-15

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF P14K INHIBITOR

#6
20250127751
2025-04-24

Traditional Chinese Medicine Compound Preparation for Tumors and Application thereof

#7
20240261250
2024-08-08

APPLICATIONS OF P14K INHIBITOR IN INTRACELLULAR PROTEIN MISFOLDING-RELATED DISEASES AND LYSOSOMAL STORAGE DISEASES

#8
20240173287
2024-05-30

Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease

#9
20240050395
2024-02-15

DEUTERATED OXOPHENYLARSINE COMPOUND AND USE THEREOF

#10
20230115711
2023-04-13

MICROMOLECULE PI4KIIIalpha INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

#11
20220362203
2022-11-17

METHOD FOR TREATING MOOD DISORDERS

#12
20220202763
2022-06-30

Arsinothricin and methods of treating infections using arsinothricin

#13
20210380672
2021-12-09

Treatment and Prevention of Cardiovascular Disease

#14
20210205260
2021-07-08

MP53 RESCUE COMPONDS AND METHODS OF TREATING A P53 DISORDER

#15
20210205259
2021-07-08

Anti-cancer agent comprising a tumour homing peptide having arsenic bonded to cysteine residues

#16
20210040195
2021-02-11

Treatment and prevention of cardiovascular disease

#17
20210038557
2021-02-11

Organoarsenic compounds and methods for the treatment of cancer

#18
20210038556
2021-02-11

Organoarsenic compounds and methods for the treatment of cancer

#19
20200323887
2020-10-15

Pharmaceutical combinations of organo-arsenoxide compounds and mTOR inhibitors

#20
20200283385
2020-09-10

Salts and prodrugs of 1-methyl-d-tryptophan

#21
20200121632
2020-04-23

Arsinothricin and methods of treating infections using arsinothricin

#22
20200069635
2020-03-05

Pharmaceutical composition for treating liver cancer, comprising tetraarsenic hexoxide crystalline polymorph

#23
20190314321
2019-10-17

Application of PI4KIIIA protein and related membrane protein complex in treating alzheimer's disease

#24
20190248739
2019-08-15

SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN

#25
20190038630
2019-02-07

Use of adenosine receptor signaling to regulate P-gp function

#26
20180134658
2018-05-17

Salts and prodrugs of 1-methyl-D-tryptophan

#27
20180085336
2018-03-29

Method for treating a glycoprotein-related disease

#28
20170355722
2017-12-14

Arsenoplatin anti-cancer agents

#29
20170326096
2017-11-16

Selective targeting of procoagulant platelets

#30
20170049742
2017-02-23

Method for treating a glycoprotein-related disease

#31
20170037070
2017-02-09

Arsenoplatin anti-cancer agents

#32
20160304546
2016-10-20

COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

#33
20160030508
2016-02-04

Antiangiogenic small molecules and methods of use

#34
20150231107
2015-08-20

Organoarsenic compounds and methods for the treatment of cancer

#35
20140148398
2014-05-29

Methods of treating giardiasis

#36
20140121165
2014-05-01

Induction of the mitochondrial permeability transition

#37
20130261082
2013-10-03

Combination Therapy With Organic Arsenicals

#38
20130143950
2013-06-06

Compounds and Methods for the Treatment of Cancer

#39
20130142730
2013-06-06

Compounds and methods for the treatment of cancer

#40
20130109762
2013-05-02

Silk particles for controlled and sustained delivery of compounds

#41
20120295861
2012-11-22

Combination Therapy With Organic Arsenicals

#42
20120129775
2012-05-24

Antiangiogenic small molecules and methods of use

#43
20120039995
2012-02-16

Arsenic compounds, their preparation methods and uses thereof

#44
20120022229
2012-01-26

Compounds and methods for the treatment of cancer

#45
20120015023
2012-01-19

Treatment of tumors prostate with arsonoliposomes

#46
20110269697
2011-11-03

ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

#47
20110092589
2011-04-21

Treatment of Inflammatory Conditions and Diseases with Metal-Thiols

#48
20110091573
2011-04-21

Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

#49
20100311689
2010-12-09

Combination therapy with organic arsenicals

#50
20090233894
2009-09-17

Compounds and methods for the treatment of cancer

#51
20090215894
2009-08-27

INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF

#52
20090162429
2009-06-25

Slow-release composition, method for the preparation thereof, and use thereof

#53
20090124579
2009-05-14

Systems and Methods For Determination of Compounds for Stimulation or Inhibition of Neocalcification

#54
20080213345
2008-09-04

Delivering Iron to an Animal

#55
20080139629
2008-06-12

Method for controlling angiogenesis in animals

#56
20070207945
2007-09-06

Extended cycle multiphasic oral contraceptive method

#57
20070183972
2007-08-09

Compounds and methods for the treatment of cancer

#58
20070065498
2007-03-22

Encapsulated arsenic drugs

#59
20060166208
2006-07-27

Induction of the mitochondrial permeability transition

#60
20060029681
2006-02-09

Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

#61
18658542
2025-09-16

Treatment of cancer using organoarsenicals

#62
18219903
2024-01-23

Arsinothricin as a multi-stage antimalarial